Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer
2004 ◽
Vol 54
(3)
◽
pp. 254-264
◽
2003 ◽
Vol 1
(5)
◽
pp. S294
2011 ◽
Vol 81
(2)
◽
pp. S68
2007 ◽
Vol 67
(1)
◽
pp. 219-224
◽
2004 ◽
Vol 58
(4)
◽
pp. 1017-1021
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4093-4093
2008 ◽
Vol 72
(1)
◽
pp. S250-S251
◽